CELG
reuters.dev
http://www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F2853710&ei=knKaUrDjLa210AHc1AE&usg=AFQjCNHJVggdXCdqil3vsPx4BF3z-GR9fw
Celgene Corp Updates On FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance
Thursday, 24 Oct 2013 07:31am EDT
Celgene Corp announced that for fiscal 2013, it expects total net product sales to exceed $6.200 billion, Net Product Sales are expected to be in the mid-to-upper end of the range of $4.200 billion to $4.300 billion ,adjusted diluted EPS guidance is raised to a range of $5.90 to $5.95 from the previous range of $5.80 to $5.90 and GAAP diluted EPS is expected to be in the range of $3.77 to $3.90. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $6.367 billion and EPS of $5.98 for fiscal 2013.Â 
